News Item

Prof. Trebicka is Head of the University of Bonn’s Laboratory for Liver Fibrosis and Portal Hypertension since 2012 in the Department of Internal Medicine. He is a recognized authority in the translational and clinical research on liver fibrogenesis, vascular liver disorders, and end-stage liver diseases. Prof. Trebicka will support Versantis' clinical activities and design VS-01 clinical program and strategy. 

Versantis secured an additional research funding to advance the R&D for its ammonia diagnostic test TS-01

Financing for a research collaboration with ETH Zurich has been secured from the Swiss Innovation Promotion Agency KTI/CTI for the development of TS-01 - an robust, precise, and flexible ammonia quantification test. These funds will be spent to optimize the technology and bring the current prototype to a validated device for hospital and point-of-care uses.